Semaglutide improves treatment satisfaction and eating behaviour in Japanese patients with type 2 diabetes mellitus.

A study published in the journal Diabetes, Obesity & Metabolism examined the effects of semaglutide injections on treatment satisfaction and eating behavior in Japanese patients with type 2 diabetes mellitus (T2DM). The study found that semaglutide injections increased treatment satisfaction and improved eating behavior in patients with T2DM, particularly those with obesity. The injections also resulted in decreased body weight and HbA1c levels in both groups. However, adverse events were reported, with loss of appetite being the most frequent. The study suggests that semaglutide injections may be a beneficial treatment option for Japanese patients with T2DM and obesity, but further research is needed to confirm these findings. [Extracted from the article]